The Evolution of Risk Assessment in Pulmonary Arterial Hypertension

Sandhya Murthy; Raymond Benza

doi:10.14797/LRPR7655

The Evolution of Risk Assessment in Pulmonary Arterial Hypertension

Methodist DeBakey Cardiovascular Journal

Volume 17 (2021): Issue 2

By: Sandhya Murthy and Raymond Benza

Open Access

|Jul 2021

Abstract

Pulmonary arterial hypertension (PAH) is a chronic debilitating disease that carries an unacceptably high morbidity and mortality rate despite improved survival with modern therapies. The combination of several modifiable and nonmodifiable variables yields a robust risk assessment across various available clinical calculators. The role of risk calculation is integral to managing PAH and aids in the timely referral to expert centers and potentially lung transplantation. Studies are ongoing to determine the role of risk calculators in the framework of clinical trials and to elucidate novel markers of high risk in PAH.

References

Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med. 2004 Oct 14; 351(16): 1655–65. doi: 10.1056/NEJMra035488.
Search in Google Scholar Back to article
Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987 Aug; 107(2): 216–23. doi: 10.7326/0003-4819-107-2-216.
Search in Google Scholar Back to article
D’Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Int Med. 1991 Sep 1; 115(5): 343–9. doi: 10.7326/0003-4819-115-5-343.
Search in Google Scholar Back to article
Barst R, Rubin L, Long W, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996 Feb 1; 334(5): 296–301. doi: 10.1056/NEJM199602013340504.
Search in Google Scholar Back to article
Galié N, Humbert M, Vachiery J, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015 Oct; 46(4): 903–75. doi: 10.1183/13993003.01032-2015.
Search in Google Scholar Back to article
Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010 Jul 13; 122(2): 164–72. doi: 10.1161/CIRCULATIONAHA.109.898122.
Search in Google Scholar Back to article
Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010 Feb; 137(2): 376–87. doi: 10.1378/chest.09-1140.
Search in Google Scholar Back to article
Umar S, Rabinovitch M, Eghbali M. Estrogen paradox in pulmonary hypertension: current controversies and future perspectives. Am J Respir Crit Care Med. 2012 Jul 15; 186(2): 125–31. doi: 10.1164/rccm.201201-0058PP.
Search in Google Scholar Back to article
Chen X, Austin ED, Talati M, et al. Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects. Eur Respir J. 2017 Aug 3; 50(2): 1602337. doi: 10.1183/13993003.02337-2016.
Search in Google Scholar Back to article
Paulin R, Michelakis ED. The Estrogen Puzzle in Pulmonary Arterial Hypertension. Circulation. 2012 Aug 28; 126(9): 1016–9. doi: 10.1161/CIRCULATIONAHA.112.126474.
Search in Google Scholar Back to article
Umar S, Iorga A, Matori H, et al. Estrogen rescues preexisting severe pulmonary hypertension in rats. Am J Respir Crit Care Med. 2011 Sep 15; 184(6): 715–23. doi: 10.1164/rccm.201101-0078OC.
Search in Google Scholar Back to article
Ventetuolo CE, Praestgaard A, Palevsky HI, Klinger JR, Halpern SD, Kawut SM. Sex and haemodynamics in pulmonary arterial hypertension. Eur Respir J. 2014 Feb; 43(2): 523–30. doi: 10.1183/09031936.00027613.
Search in Google Scholar Back to article
Shapiro S, Traiger GL, Turner M, et al. Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Chest. 2012 Feb; 141(2): 363–73. doi: 10.1378/chest.10-3114.
Search in Google Scholar Back to article
Karnes JH, Wiener HW, Schwantes-An T-H, et al. Genetic Admixture and Survival in Diverse Populations with Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2020 Jun 1; 201(11): 1407–1415. doi: 10.1164/rccm.201907-1447OC.
Search in Google Scholar Back to article
Davis KK, Lilienfeld DE, Doyle RL. Increased mortality in African Americans with idiopathic pulmonary arterial hypertension. J Natl Med Assoc. 2008 Jan; 100(1): 69–72. doi: 10.1016/s0027-9684(15)31177-9.
Search in Google Scholar Back to article
Chung L, Liu J, Parsons L, et al. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. Chest. 2010 Dec; 138(6): 1383–94. doi: 10.1378/chest.10-0260.
Search in Google Scholar Back to article
Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2004 Jun 16; 43(12 Suppl S): 40S–47S. doi: 10.1016/j.jacc.2004.02.032.
Search in Google Scholar Back to article
Taichman DB, McGoon MD, Harhay MO, et al. Wide variation in Clinicians Assessment of New York Heart Association/World Health Organization Functional Class in Patients with Pulmonary Arterial Hypertension. May Clin Proc. 2009; 84(7): 586–592. doi: 10.4065/84.7.586.
Search in Google Scholar Back to article
Lewis RA, Armstrong I, Bergbaum C, et al. EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disase-associated pulmonary arterial hypertension: results from a UK multicenter study. Eur Respir J. 2021; 57(2): 211124. doi: 10.1183/13993003.00124-2020.
Search in Google Scholar Back to article
Macchia A, Marchioli R, Marfisi R, et al. A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology. Am Heart J. 2007 Jun; 153(6): 1037–47. doi: 10.1016/j.ahj.2007.02.037.
Search in Google Scholar Back to article
Farber HW, Miller DP, McGoon MD, Frost AE, Benton WW, Benza RL. Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance. J Heart Lung Trans. 2015 Mar; 34(3): 362–8. doi: 10.1016/j.healun.2014.08.020.
Search in Google Scholar Back to article
Wensel R, Opitz CF, Anker SD, et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation. 2002 Jul 16; 106(3): 319–24. doi: 10.1161/01.cir.0000022687.18568.2a.
Search in Google Scholar Back to article
Shah SJ, Thenappan T, Rich S, Sur J, Archer SL, Gomberg-Maitland M. Value of exercise treadmill testing in the risk stratification of patients with pulmonary hypertension. Circ Heart Fail. 2009 Jul; 2(4): 278–86. doi: 10.1161/CIRCHEARTFAILURE.108.807826.
Search in Google Scholar Back to article
Fu S, Ping P, Zhu Q, Ye P, Luo L. Brain Natriuretic Peptide and Its Biochemical, Analytical, and Clinical Issues in Heart Failure: A Narrative Review. Front Physiol. 2018 Jun 5; 9: 692. doi: 10.3389/fphys.2018.00692.
Search in Google Scholar Back to article
Chin KM, Channick RN, Kim NH, Rubin LJ. Central venous blood oxygen saturation monitoring in patients with chronic pulmonary arterial hypertension treated with continuous IV epoprostenol: correlation with measurements of hemodynamics and plasma brain natriuretic peptide levels. Chest. 2007 Sep; 132(3): 786–92. doi: 10.1378/chest.07-0694.
Search in Google Scholar Back to article
Williams MH, Handler CE, Akram R, et al. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. Eur Heart J. 2006 Jun; 27(12): 1485–94. doi: 10.1093/eurheartj/ehi891.
Search in Google Scholar Back to article
Mauritz G, Rizopoulos D, Groepenhoff H, et al. Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension. Am J Cardiol. 2011 Dec 1; 108(11): 1645–50. doi: 10.1016/j.amjcard.2011.07.025.
Search in Google Scholar Back to article
Simpson CE, Damico RL, Hassoun PM, et al. Noninvasive Prognostic Biomarkers for Left-Sided Heart Failure as Predictors of Survival in Pulmonary Arterial Hypertension. Chest. 2020 Jun; 157(6): 1606–16. doi: 10.1016/j.chest.2019.12.037.
Search in Google Scholar Back to article
Chakinala MM, Coyne DW, Benza RL, et al. Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysis. J Heart Lung Transplant. 2018 Jun; 37(6): 696–705. doi: 10.1016/j.healun.2017.10.028.
Search in Google Scholar Back to article
Quarck R, Nawrot T, Meyns B, et al. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol. 2009 Apr 7; 53(14): 1211–8. doi: 10.1016/j.jacc.2008.12.038.
Search in Google Scholar Back to article
Lannan KL, Phipps RP, White RJ. Thrombosis, platelets, microparticles and PAH: more than a clot. Drug Discov Today. 2014 Aug; 19(8): 1230–5. doi: 10.1016/j.drudis.2014.04.001.
Search in Google Scholar Back to article
Samokhin AO, Hsu S, Yu PB, et al. Circulating NEDD9 is increased in pulmonary arterial hypertension: A multicenter, retrospective analysis. J Heart Lung Transplant. 2020 Apr; 39(4): 289–299. doi: 10.1016/j.healun.2019.12.002.
Search in Google Scholar Back to article
Raymond RJ, Hinderliter AL, Willis PW, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol. 2002 Apr 3; 39(7): 1214–9. doi: 10.1016/s0735-1097(02)01744-8.
Search in Google Scholar Back to article
Austin C, Alassas K, Burger C, et al. Echocardiographic assessment of estimated right atrial pressure and size predicts mortality in pulmonary arterial hypertension. Chest. 2015 Jan; 147(1): 198–208. doi: 10.1378/chest.13-3035.
Search in Google Scholar Back to article
Forfia PR, Fisher MR, Mathai SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med. 2006 Nov 1; 174(9): 1034–41. doi: 10.1164/rccm.200604-547OC.
Search in Google Scholar Back to article
Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010 Jul; 23(7): 685–713; quiz 786–8. doi: 10.1016/j.echo.2010.05.010.
Search in Google Scholar Back to article
D’Alto M, Badagliacca R, Argiento P, et al. Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension. Chest. 2020 Feb; 157(2): 376–83. doi: 10.1016/j.chest.2019.09.009.
Search in Google Scholar Back to article
Boxt LM, Katz J, Kolb T, Czegledy FP, Barst RJ. Direct quantitation of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension. J Am Coll Cardiol. 1992 Jun; 19(7): 1508–15. doi: 10.1016/0735-1097(92)90611-p.
Search in Google Scholar Back to article
Roeleveld RJ, Marcus JT, Boonstra A, et al. A comparison of noninvasive MRI-base methods of estimating pulmonary artery pressure in pulmonary hypertension. J Magn Reson Imaging. 2005 Jul; 22(1): 67–72. doi: 10.1002/jmri.20338.
Search in Google Scholar Back to article
Beerbaum P, Körperich H, Barth P, Esdorn H, Gieseke J, Meyer H. Noninvasive quantification of left-to-right shunt in pediatric patients: phase-contrast cine magnetic resonance imaging compared with invasive oximetry. Circulation. 2001 May 22; 103(20): 2476–82. doi: 10.1161/01.cir.103.20.2476.
Search in Google Scholar Back to article
Baggen VJ, Leiner T, Post MC, et al. Cardiac magnetic resonance findings predicting mortality in patients with pulmonary arterial hypertension: a systematic review and meta-analysis. Eur Radiol. 2016 Nov; 26(11): 3771–80. doi: 10.1007/s00330-016-4217-6.
Search in Google Scholar Back to article
Sieren MM, Berlin C, Oechtering TH, et al. Comparison of 4D Flow MRI to 2D Flow MRI in the pulmonary arteries in healthy volunteers and patients with pulmonary hypertension. PLoS One. 2019 Oct 24; 14(10): e0224121. doi: 10.1371/journal.pone.0224121.
Search in Google Scholar Back to article
Kelly RP, Ting CT, Yang TM, et al. Effective arterial elastance as index of arterial vascular load in humans. Circulation. 1992 Aug; 86(2): 513–21. doi: 10.1161/01.cir.86.2.513.
Search in Google Scholar Back to article
Sunagawa K, Maughan WL, Sagawa K. Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle. Circ Res. 1985 Apr; 56(4): 586–95. doi: 10.1161/01.res.56.4.586.
Search in Google Scholar Back to article
Tello K, Dalmer A, Axmann J, et al. Reserve of Right Ventricular-Arterial Coupling in the Setting of Chronic Overload. Circ Heart Fail. 2019 Jan; 12(1): e005512. doi: 10.1161/CIRCHEARTFAILURE.118.005512.
Search in Google Scholar Back to article
Noordegraaf AV, Channick R, Cottreel E, et al. Results from the REPAIR study final analysis: Effects of macitentan on right ventricular (RV) remodeling in pulmonary arterial hypertension (PAH). J Heart Lung Trans. 2020 Apr; 39(4): S16–17. doi: 10.1016/j.healun.2020.01.1140.
Search in Google Scholar Back to article
Scott J, Lohmueller L, Kraisangka J, Kanwar M, Benza R. Abstract 1174: Hemodynamic parameters in predicting survival in pulmonary arterial hypertension. Presented at: CHEST Annual Meeting 2019; 2019 Oct 19–23; New Orleans, LA.
Search in Google Scholar Back to article
Sun X, Hansen JE, Oudiz RJ, Wasserman K. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol. 2003 Mar 19; 41(6): 1028–35. doi: 10.1016/s0735-1097(02)02964-9.
Search in Google Scholar Back to article
Chandra S, Shah SJ, Thenappan T, Archer SL, Rich S, Gomberg-Maitland M. Carbon monoxide diffusing capacity and mortality in pulmonary arterial hypertension. J Heart Lung Transplant. 2010 Feb; 29(2): 181–7. doi: 10.1016/j.healun.2009.07.005.
Search in Google Scholar Back to article
Benza RL, Gomberg-Maitland M, Miller DP, et al. The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension. Chest. 2012 Feb; 141(2): 354–362. doi: 10.1378/chest.11-0676.
Search in Google Scholar Back to article
Weatherald J, Huertas A, Boucly A, et al. Association between BMI and obesity with survival in pulmonary arterial hypertension. Chest. 2018 Oct 1; 154(4): P872–881. doi: 10.1016/j.chest.2018.05.006.
Search in Google Scholar Back to article
Aldred MA, Vijayakrishnan J, James V, et al. BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension. Hum Mutat. 2006 Feb; 27(2): 212–3. doi: 10.1002/humu.9398.
Search in Google Scholar Back to article
Ma L, Chung WK. The genetic basis of pulmonary arterial hypertension. Hum Genet. 2014 May; 133(5): 471–9. doi: 10.1007/s00439-014-1419-3.
Search in Google Scholar Back to article
Evans JDW, Girerd B, Montani D, et al. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis. Lancet Respir Med. 2016 Feb; 4(2): 129–37. doi: 10.1016/S2213-2600(15)00544-5.
Search in Google Scholar Back to article
Benza RL, Gomberg-Maitland M, Demarco T, et al. Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2015 Dec 1; 192(11): 1345–54. doi: 10.1164/rccm.201501-0196OC.
Search in Google Scholar Back to article
Rhodes CJ, Batai K, Bleda M, et al. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis. Lancet Respir Med. 2019 Mar; 7(3): 227–238. doi: 10.1016/S2213-2600(18)30409-0.
Search in Google Scholar Back to article
Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006 May 1; 173(9): 1023–30. doi: 10.1164/rccm.200510-1668OC.
Search in Google Scholar Back to article
Benza RL, Elliott CG, Farber HW, et al. Updated risk score calculator for pulmonary arterial hypertension patients. J Heart Lung Trans. 2017 Apr; 36(4): S19. doi: 10.1016/j.healun.2017.01.038.
Search in Google Scholar Back to article
Benza RL, Kanwar MK, Raina A, et al. Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension. Chest. 2021 Jan; 159(1): 337–346. doi: 10.1016/j.chest.2020.08.2069.
Search in Google Scholar Back to article
Benza RL, Gomberg-Maitland M, Elliott CG, et al. Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies. Chest. 2019 Aug; 156(2): 323–337. doi: 10.1016/j.chest.2019.02.004.
Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.14797/LRPR7655 | Journal eISSN: 1947-6108

Journal RSS Feed

Language: English

Page range: 134 - 144

Accepted on: Nov 18, 2020

Published on: Jul 1, 2021

Published by: Houston Methodist DeBakey Heart & Vascular Center

In partnership with: Paradigm Publishing Services

Keywords:

risk,

pulmonary arterial hypertension,

survival,

prognosis

© 2021 Sandhya Murthy, Raymond Benza, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.

Volume 17 (2021): Issue 2